Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy

NCT05443178 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis Infection

Interventions

DRUG: Nivaquine ® (Chloroquine)

Sponsor

University of Zurich